Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0381319810200030065
Korean Journal of Occupational Health
1981 Volume.20 No. 3 p.65 ~ p.71
Urinary Lead Excretion Under Various Dosage Schedule of Oral D-penicillamine


Abstract
2,3-Dimercapto-1-propanol (BAL), edathamil calcium disodium (Ca-EDTA) and d-penicillamine (D-PCA) are three typical chelating agents in the treatment of lead poisoning.
Of these, D-PCA is relatively non-toxic and it¢¥s oral efficacy provides a definite advantage, particularly for the long periods of "be-leading" that are often required in lead poisoning.
In order to observe the effect of various dosage schedule of oral D-PCA on urinary lead excretion (ULE), 200~1200§· of oral D-PCA were administered on 90 lead patients for 5 days according to the dosage schedule and 24-hour ULE before and during D-PCA administration were measured by dithizon method.
The results were as follows;
1. Five-day average daily ULE increased by approximately 2 to 5 times after daily oral D-PCA of 200~1200§· as compared with initial excretion.
Even with 200§· per day, significant increase of ULE was noted.
2. With the same daily dose, ULE was observed, as the higher single dose was given less often.
3. Of all 9 groups, 400§· b.i.d. and t.i.d. groups showed on largest ULE, reaching 4~5 times as compared with initial excretion.
4. Increment of ULE was largest on the 1st day, decreased gradually as D-PCA administration proceeded, and showed the significant fall on 5th day.
KEYWORD
FullTexts / Linksout information
Listed journal information